• LIVING WITH CRC

    Comprehensive Review Examines Mechanisms and Management of Irinotecan-Induced Delayed Diarrhea

    A systematic review details how irinotecan's active metabolite SN38 affects the intestinal microenvironment—including flora disruption, immune dysregulation, and barrier impairment—and explores current therapeutic approaches to manage this common side effect. (Pharmaceuticals)